CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,119,848
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,119,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-10 | Adcock Richard CEO & President | Option exercise · Restricted Stock Units | −274,122 | 548,246 | ||
| 2026-02-10 | LAUER REGAN J Chief Accounting Officer | Option exercise | +5,482 | 115,740 | ||
| 2026-02-10 | LAUER REGAN J Chief Accounting Officer | Shares withheld for taxes | −2,257 | $6.93 | $16K | 113,483 |
| 2026-02-10 | LAUER REGAN J Chief Accounting Officer | Option exercise · Restricted Stock Units | −5,482 | 10,965 | ||
| 2026-02-10 | SOON-SHIONG PATRICK See remarks | Option exercise | +274,122 | 29,820,312 | ||
| 2026-02-10 | SOON-SHIONG PATRICK See remarks | Shares withheld for taxes | −118,560 | $6.93 | $822K | 29,701,752 |
| 2026-02-10 | SOON-SHIONG PATRICK See remarks | Option exercise · Restricted Stock Units | −274,122 | 548,246 | ||
| 2026-01-20 | Selecky Christobel Director | Option exercise 10b5-1 | +25,000 | $2.98 | $75K | 25,000 |
| 2026-01-20 | Selecky Christobel Director | Sale 10b5-1 | −25,000 | $7.51 | $188K | 0 |
| 2026-01-20 | Selecky Christobel Director | Option exercise · Stock Option (right to buy) 10b5-1 | −25,000 | 92,937 | ||
| 2026-01-20 | Simon Barry J. Director | Sale 10b5-1 | −76,967 | $6.54 | $503K | 3,166,604 |
| 2026-01-20 | Simon Barry J. Director | Sale 10b5-1 | −75,000 | $7.88 | $591K | 3,091,604 |
| 2026-01-16 | Selecky Christobel Director | Option exercise 10b5-1 | +50,000 | $2.98 | $149K | 50,000 |
| 2026-01-16 | Selecky Christobel Director | Sale 10b5-1 | −50,000 | $5.00 | $250K | 0 |
| 2026-01-16 | Selecky Christobel Director | Option exercise · Stock Option (right to buy) 10b5-1 | −50,000 | 117,937 | ||
| 2025-12-31 | Sachs David C. Chief Financial Officer | Option exercise | +30,397 | 256,017 | ||
| 2025-12-31 | Sachs David C. Chief Financial Officer | Shares withheld for taxes | −15,435 | $1.98 | $31K | 240,582 |
| 2025-12-31 | Sachs David C. Chief Financial Officer | Option exercise · Restricted Stock Units | −30,397 | 45,602 | ||
| 2025-12-31 | Adcock Richard CEO & President | Option exercise | +34,483 | 368,901 | ||
| 2025-12-31 | Adcock Richard CEO & President | Shares withheld for taxes | −17,510 | $1.98 | $35K | 351,391 |
Page 4 of 12 · 226 trades